290
Views
70
CrossRef citations to date
0
Altmetric
Research Article

Hepatic Lipase Deficiency

&
Pages 547-572 | Published online: 29 Sep 2008

References

  • Bruce C, Chouinard RA Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998; 18: 297–330.
  • Stahnke G, Sprengel R, Augustin J, et al. Human hepatic triglyceride lipase: cDNA cloning, amino acid sequence and expression in a cultured cell line. Differentiation 1987; 35: 45–52.
  • Komaromy MC, Schotz MC. Cloning of rat hepatic lipase cDNA: evidence for a lipase gene family. Proc Natl Acad Sci USA 1987; 84: 1526–30.
  • Hide WA, Chan L Li WH. Structure and evolution of the lipase superfamily. J Lipid Res 1992; 33: 167–78.
  • Wolle J, Jansen H, Smith LC, et al. Functional role of N-linked glycosylation in human hepatic lipase: asparagine-56 is important for both enzyme activity and secretion. J Lipid Res 1993; 34: 2169–76.
  • Hill JS, Davis RC, Yang D, et al. Human hepatic lipase subunit structure determination. J Biol Chem 1996; 271: 22931–6.
  • Hill JS, Davis RC, Yang D, et al. Hepatic lipase: high-level expression and subunit structure determination. Methods Enzymol 1997; 284: 232–46.
  • Nilsson A, Landin B Schotz MC. Hydrolysis of chylomicron arachidonate and linoleate ester bonds by lipoprotein lipase and hepatic lipase. J Lipid Res 1987; 28: 510–7.
  • Thuren T, Weisgraber KH, Sisson P, et al. Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins. Biochemistry 1992; 31: 2332–8.
  • Jackson RL. Lipoprotein lipase and hepatic lipase. Boyer, P. Ed. The Enzymes., vol. 16. New York: Academic Press; 1983; p. 141–81.
  • Persoon NL, Hulsmann WC Jansen H. Localization of the salt-resistant heparin-releasable lipase in the rat liver, adrenal and ovary. Eur J Cell Biol 1986; 41: 134–7.
  • Laposata EA, Laboda HM, Glick JM, et al. Hepatic lipase. Synthesis, processing, and secretion by isolated rat hepatocytes. J Biol Chem 1987; 262: 5333–8.
  • Breedveld B, Schoonderwoerd K, Verhoeven AJ, et al. Hepatic lipase is localized at the parenchymal cell microvilli in rat liver. Biochem J 1997; 321: 425–30.
  • Persoon NL, Sips HJ, Hulsmann WC, et al. Monoclonal antibodies against salt-resistant rat liver lipase. Cross-reactivity with lipases from rat adrenals and ovaries. Biochim Biophys Acta 1986; 875: 286–92.
  • Hixenbaugh EA, Sullivan TRJ, Strauss JF, Hepatic lipase in the rat ovary. Ovaries cannot synthesize hepatic lipase but accumulate it from the circulation. J Biol Chem 1989; 264: 4222–30.
  • Verhoeven AJ, Jansen H. Hepatic lipase mRNA is expressed in rat and human steroidogenic organs. Biochim Biophys Acta 1994; 1211: 121–4.
  • Verhoeven AJ, Jansen H. The rat hepatic lipase gene is expressed into two different proteins in liver, adrenals and ovaries. Z Gastroenterol 1996; 34(Suppl): 54–55.
  • Murtomaki S, Tahvanainen E, Antikainen M, et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 1997; 17: 1879–84.
  • Guerra R, Wang J, Grundy SM, et al. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997; 94: 4532–7.
  • Jansen H, Verhoeven AJ, Weeks L, et al. Common C-to-T substitution at position-480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997; 17: 2837–42.
  • Tahvanainen E, Syvanne M, Frick MH, et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest 1998; 101: 956–60.
  • Vega GL, Clark LT, Tang A, et al. Hepatic lipase activity is lower in African-American men than in white American men: effects of 5¢ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998; 39: 228–32.
  • Martin GA, Busch SJ, Meredith GD, et al. Isolation and cDNA sequence of human postheparin plasma hepatic triglyceride lipase. J Biol Chem 1988; 263: 10907–14.
  • Nie L, Niu S, Vega GL, et al. Three polymorphisms associated with low hepatic lipase activity are common in African-Americans. J Lipid Res 1998; 39: 1900–3.
  • Breckenridge WC, Little JA, Alaupovic P, et al. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 1982; 45: 161–79.
  • Auwerx JH, Babirak SP, Hokanson JE, et al. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet 1990; 46: 470–7.
  • Brand K, Dugi KA, Brunzell JD, et al. A novel A®G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res 1996; 37: 1213–23.
  • Hegele RA, Little JA Connelly PW. Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochem Biophys Res Commun 1991; 179: 78–84.
  • Hegele RA, Little JA, Vezina C, et al. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 1993; 13: 720–8.
  • Durstenfeld A, Ben-Zeev O, Reue K, et al. Molecular characterization of human hepatic lipase deficiency. In vitro expression of two naturally occurring mutations. Arterioscler Thromb 1994; 14: 381–5.
  • Hegele RA, Tu L Connelly PW. Human hepatic lipase mutations and polymorphisms. Hum Mutat 1992; 1: 320–4.
  • Lipid Research Clinic Population Studies Data Book. The Prevalence study. N.I.H. Publication No. 82.2014 ed. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1982.
  • Emi M, Wilson DE, Iverius P-H, Wu L, et al. Missense mutation (Gly>Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem 1990; 265: 5910–6.
  • Emi M, Hegele RA, Hopkins PN, et al. Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes. Arterioscler Thromb 1991; 11: 1349–55.
  • Hegele RA, Breckenridge WC, Cox DW, et al. Interaction between variant apolipoproteins C-II and E that affects plasma lipoprotein concentrations. Arterioscler Thromb 1991; 11: 1303–9.
  • Cianflone K, Bilodeau M, Davignon J, et al. Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor. Metabolism 1990; 39: 272–80.
  • Weintraub MS, Eisenberg S Breslow JL. Lovastatin reduces post-prandial lipo-protein levels in hypercholesterolemic patients with mild hypertriglyceridemia. Eur J Clin Invest 1989; 19: 480–5.
  • Huff MW, Sawyez CG, Connelly PW, et al. Beta-VLDL in hepatic lipase deficiency induces apoE-mediated cholesterol ester accumulation in macroph-ages. Arterioscler Thromb 1993; 13: 1282–90.
  • Connelly PW, Ranganathan S, Maguire GF, et al. The b-very low density lipoprotein present in hepatic lipase deficiency competitively inhibits low density lipoprotein binding to fibroblasts and stimulates fibroblast acyl-CoA: cholesterolacyltransferase. J Biol Chem 1988; 263: 14184–8.
  • Connelly PW, Maguire GF, Lee M, et al. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 1990; 10: 40–8.
  • Shinomiya M, Sasaki N, Barnhart RL, Shirai K, Jackson RL. Effect of apolipoproteins on the hepatic lipase-catalyzed hydrolysis of human plasma high density lipoprotein 2-triacylglycerols. Biochim Biophys Acta 1982; 713: 292–9.
  • Nozaki S, Kubo M, Sudo H, et al. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein—postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals. Metabolism 1986; 35: 53–8.
  • Deleted in proof.
  • Demant T, Carlson LA, Holmquist L, et al. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988; 29: 1603–11.
  • Landin B, Nilsson A, Twu JS, et al. A role for hepatic lipase in chylomicron and high density lipoprotein phospholipid metabolism. J Lipid Res 1984; 25: 559–63.
  • Landis BA, Rotolo FS, Meyers WC, et al. Influence of apolipoprotein E on soluble and heparin-immobilized hepatic lipase. Am J Physiol 1987; 252: G805–10.
  • Sultan F, Lagrange D, Le Liepvre X, et al. Chylomicron-remnant uptake by freshly isolated hepatocytes. Effect of heparin and of hepatic triacylglycerol lipase. Biochem J 1989; 258: 587–94.
  • Havel RJ. Chylomicron remnants: hepatic receptors and metabolism. Curr Opin Lipidol 1995; 6: 312–6.
  • Diard P, Malewiak MI, Lagrange D, et al. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepa-tocytes. Biochem J 1994; 299: 889–94.
  • Weintraub MS, Eisenberg S Breslow JL. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyperlipoproteinemic individuals. J Clin Invest 1987; 79: 1110–9.
  • Rubinstein A, Gibson JC, Paterniti JRJ, et al. Effect of heparin-induced lipolysis on the distribution of apolipoprotein E among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. J Clin Invest 1985; 75: 710–21.
  • Tall AR. Metabolic and genetic control of HDL cholesterol levels. J Intern Med 1992; 231: 661–8.
  • Deckelbaum RJ, Bramkrishnan R, Eisenberg S, et al. Triacylglycerol and phos-pholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. Biochemistry 1992; 31: 8544–51.
  • Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but not A-II. J Biol Chem 1984; 259: 12201–9.
  • Mowri HO, Patsch W, Smith LC, et al. Different reactivities of high density lipoprotein2 subfractions with hepatic lipase. J Lipid Res 1992; 33: 1269–79.
  • Mowri HO, Patsch JR, Ritsch A, et al. High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase. J Lipid Res 1994; 35: 291–300.
  • Mowri HO, Patsch JR, Gotto AM, Jr., et al. Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arterioscler Thromb Vasc Biol 1996; 16: 755–62.
  • Clay MA, Newnham HH Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high-density lipoproteins during incubation in vitro. Arteriosclerosis Thrombosis 1991; 11: 415–22.
  • Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages. Formation of high-density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 1991; 266: 3080–6.
  • Cheung AK, Parker CJ, Ren K, et al. Increased lipase inhibition in uremia: identification of pre-beta-HDL as a major inhibitor in normal and uremic plasma. Kidney Int 1996; 49: 1360–71.
  • Rader DJ, Castro G, Zech LA, et al. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II. J Lipid Res 1991; 32: 1849–59.
  • Jansen H, Hulsman WC. Heparin-releasable (liver) lipase(s) may play a role in the uptake of cholesterol by steroid-secreting tissues. Trends Biochem Sci 1980; 5: 265–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.